Weijie Wu

612 citations
32 papers · 436 indexed · h-index 14
Topics
Nerve injury and regeneration (5 papers)Signaling Pathways in Disease (3 papers)RNA Research and Splicing (3 papers)
Journals
Nature CommunicationsSHILAP Revista de lepidopterologíaChemical Engineering Journal
Partner nations
ChinaHong KongAustralia

In The Last Decade

Weijie Wu

30 papers receiving 434 citations

Peers

Weijie Wu
Comparison fields: 5 of 98
  • Molecular Biology 142
  • Biomedical Engineering 88
  • Cellular and Molecular Neuroscience 49
  • Cancer Research 46
  • Materials Chemistry 46
Replace Sanjoy Dutta with:
Sanjoy Dutta United States
Yubo Zhou China
Yongliang Cao China
Daxin Wang China
Xinxin Yan China
Ying-Hui Chen Taiwan
Sevim Işık Türkiye
Noora M. Hameed Iraq
Carla P. Gomes Portugal
Weijie Wu relative to Sanjoy Dutta United States Sanjoy Dutta's profile →
Citations per field
00.5×
Sanjoy Dutta · 1×
Citations per year

Countries citing papers authored by Weijie Wu

Since Specialization
Citations

This map shows the geographic impact of Weijie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Wu more than expected).

Fields of papers citing papers by Weijie Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Wu. The network helps show where Weijie Wu may publish in the future.

Co-authorship network of co-authors of Weijie Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weijie Wu. A scholar is included among the top collaborators of Weijie Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijie Wu. Weijie Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 4
5 16
6 30
7 37
8 19
9 4
10 10
11 1
12 2
13 4
14 8
15 8
16 24
17 13
18 20
19 8
20 13

About Weijie Wu

Weijie Wu is a scholar working on Geriatrics and Gerontology, Cellular and Molecular Neuroscience and Urology, having authored 32 papers that have together received 436 indexed citations. Recurring topics across this work include Nerve injury and regeneration (5 papers), Signaling Pathways in Disease (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Molecular Medicine (40 citations), Developmental Neuroscience (13 citations) and Cancer Research (46 citations). Weijie Wu has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Youhua Wang, Meifang Zhu, Mengge Xia, Patrick Théato, Fengwei Liu, Linlin Wang, Fangjie Zhang, Haijiao Xie, Yuxi Liu and Longfei Wang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Chemical Engineering Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026